Cargando…
P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431001/ http://dx.doi.org/10.1097/01.HS9.0000971360.55140.cd |
_version_ | 1785091094856335360 |
---|---|
author | Roost Clausen, Michael Belada, David Offner, Fritz de Vos, Sven Brody, Joshua Linton, Kim Snauwaert, Sylvia Cordoba, Raul Wu, Jun Bykhovski, Irina Wang, Liwei Rana, Ali Falchi, Lorenzo |
author_facet | Roost Clausen, Michael Belada, David Offner, Fritz de Vos, Sven Brody, Joshua Linton, Kim Snauwaert, Sylvia Cordoba, Raul Wu, Jun Bykhovski, Irina Wang, Liwei Rana, Ali Falchi, Lorenzo |
author_sort | Roost Clausen, Michael |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104310012023-08-17 P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE Roost Clausen, Michael Belada, David Offner, Fritz de Vos, Sven Brody, Joshua Linton, Kim Snauwaert, Sylvia Cordoba, Raul Wu, Jun Bykhovski, Irina Wang, Liwei Rana, Ali Falchi, Lorenzo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431001/ http://dx.doi.org/10.1097/01.HS9.0000971360.55140.cd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Roost Clausen, Michael Belada, David Offner, Fritz de Vos, Sven Brody, Joshua Linton, Kim Snauwaert, Sylvia Cordoba, Raul Wu, Jun Bykhovski, Irina Wang, Liwei Rana, Ali Falchi, Lorenzo P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE |
title | P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE |
title_full | P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE |
title_fullStr | P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE |
title_full_unstemmed | P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE |
title_short | P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE |
title_sort | p1116: high complete metabolic response rates with epcoritamab + r-chop in previously untreated (1l) patients with high-risk diffuse large b-cell lymphoma, including double/triple-hit: epcore nhl-2 update |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431001/ http://dx.doi.org/10.1097/01.HS9.0000971360.55140.cd |
work_keys_str_mv | AT roostclausenmichael p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT beladadavid p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT offnerfritz p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT devossven p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT brodyjoshua p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT lintonkim p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT snauwaertsylvia p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT cordobaraul p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT wujun p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT bykhovskiirina p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT wangliwei p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT ranaali p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update AT falchilorenzo p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update |